Literature DB >> 2843577

C1q enhancement of antibody-dependent granulocyte-mediated killing of nonphagocytosable targets in vitro.

A Hamada1, J Young, R A Chmielewski, B M Greene.   

Abstract

A possible role for C1q in antibody-dependent granulocyte-mediated killing of nonphagocytosable targets was investigated utilizing IgG-dependent granulocyte cytotoxicity directed against microfilariae of Dirofilaria immitis. Granulocyte-mediated killing of microfilariae is enhanced by addition of fresh serum. Lack of C4 did not significantly reduce the observed increase in cytotoxicity. The addition of highly purified monomeric human Clq (0.2 microgram/ml) in the presence of immune IgG resulted in a two- to fivefold enhancement of killing (P less than 0.025). C1q enhancement of killing occurred in the absence of fluid-phase IgG, but killing was significantly less than when both fluid-phase IgG and C1q were present. The effect of C1q was inhibited by the addition of solubilized type I collagen (44-92% inhibition of killing, P less than 0.05). Significant 125I-Clq binding to microfilariae occurred only in the presence of immune IgG. In addition, C1q in concentrations ranging from 0.5 to 2.0 micrograms/ml resulted in a dose-dependent increase in binding of 125I-immune IgG to microfilariae. Finally, when purified C1q was added to preopsonized, washed microfilariae, granulocyte production of superoxide was increased from 0.25 +/- 0.07 to 0.68 +/- 0.07 nm/10(6) cells.10 min (P less than 0.01). These results describe a novel functional role for C1q in enhancement of antibody-dependent cellular cytotoxicity towards nonphagocytosable targets.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843577      PMCID: PMC303606          DOI: 10.1172/JCI113702

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Active disassembly of the first complement component, C-1, by C-1 inactivator.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

3.  Spectrum of horse-heart cytochrome c.

Authors:  E MARGOLIASH; N FROHWIRT
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

4.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

5.  Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a).

Authors:  W F Rosse; T Borsos; H J Rapp
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

6.  Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.

Authors:  A Hamada; B M Greene
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

7.  Characterization of the C1q receptor on a human macrophage cell line, U937.

Authors:  J Arvieux; A Reboul; J C Bensa; M G Colomb
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

Review 8.  Preparation and properties of human C1 inhibitor.

Authors:  R B Sim; A Reboul
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  In vitro immune mechanisms associated with clearance of microfilariae of Dirofilaria immitis.

Authors:  W M El-Sadr; M Aikawa; B M Greene
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

10.  Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.

Authors:  D A Bobak; T A Gaither; M M Frank; A J Tenner
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

View more
  6 in total

1.  Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

Authors:  R H van den Berg; C E Siegert; M C Faber-Krol; T W Huizinga; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection.

Authors:  Joanna Warren; Pietro Mastroeni; Gordon Dougan; Mahdad Noursadeghi; Jonathan Cohen; Mark J Walport; Marina Botto
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Protective and inactivating effects of neutrophil myeloperoxidase on C1q activity.

Authors:  G Zabucchi; R Menegazzi; L Roncelli; P Bertoncin; F Tedesco; P Patriarca
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

4.  Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines.

Authors:  C Alvarez-Dominguez; E Carrasco-Marin; F Leyva-Cobian
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Distinct N-Linked Immunoglobulin G Glycosylation Patterns Are Associated With Chronic Pathology and Asymptomatic Infections in Human Lymphatic Filariasis.

Authors:  Tomabu Adjobimey; Achim Hoerauf
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

6.  Novel insights into the transcriptome of Dirofilaria immitis.

Authors:  Yan Fu; Jingchao Lan; Zhihe Zhang; Rong Hou; Xuhang Wu; Deying Yang; Runhui Zhang; Wanpeng Zheng; Huaming Nie; Yue Xie; Ning Yan; Zhi Yang; Chengdong Wang; Li Luo; Li Liu; Xiaobin Gu; Shuxian Wang; Xuerong Peng; Guangyou Yang
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.